What the company does
Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also develops VLA15, a vaccine candidate against Borrelia, the bacterium that causes Lyme disease; S4V2, a tetravalent bioconjugate vaccine candidate …
What the weekly tape is saying
VLA closed the latest completed week at 2.29 EUR. The 4-week return is -7.7% and the 12-week return is -48.0%. Trend Signal is inactive, Market Dynamics is -1.13. Setup signature: Risk-first tape with a 13/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 3.50 EUR
- Vs Trend Line
- -34.6%
- Fair Value
- 3.76 EUR
- Vs Fair Value
- -39.1%
- 52W High
- 5.30 EUR
- 52W Low
- 2.14 EUR
- Drawdown
- -56.8%
- Range Position
- 4.7%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 31
- 52W Active Breadth
- 59.6%
- Sector Scope
- AT Healthcare
- Sector Rank
- 82 of 112
- Sector Percentile
- 27.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AT Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.0%
- Avg 4W
- 3.6%
- Trend Breadth
- 35.0%
- Positive MD
- 42.0%
AT Biotechnology
- Tracked Peers
- 21
- 4W Rank
- 17 of 21
- Avg 1W
- -2.5%
- Avg 4W
- 0.3%
- Trend Breadth
- 23.8%
- Positive RS
- 9.5%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.13
- 4W MD Change
- 4.7%
- Relative Strength
- -48.13
- 4W RS Change
- -16.3%
- Expectation
- Negative
- Probability
- 41.74%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 16.6K
- 13W Average
- 51.3K
- 52W Average
- 47.6K
- Vs 13W
- 0.3x
- Vs 52W
- 0.3x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 10.6%
- 52W Volatility
- 11.2%
- Upside Weeks
- 25
- Downside Weeks
- 27
- Downside Breadth
- 51.9%
- Avg Gain / Loss
- 8.8% / -7.5%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- VIE
- Country
- AT
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- EUR
- Market Cap
- 484.9M
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 2.29 EUR | -3.0% | 3.50 EUR | 3.76 EUR | -1.13 | -48.13 | 16.6K | Off |
| 5 Jun 2026 | 2.36 EUR | -11.0% | 3.55 EUR | 3.79 EUR | -1.00 | -45.38 | 23.3K | Off |
| 29 May 2026 | 2.65 EUR | 6.3% | 3.59 EUR | 3.81 EUR | -1.00 | -39.64 | 40.7K | Off |
| 22 May 2026 | 2.50 EUR | 0.6% | 3.64 EUR | 3.83 EUR | -1.12 | -41.91 | 30.1K | Off |
| 15 May 2026 | 2.48 EUR | 2.7% | 3.69 EUR | 3.85 EUR | -1.18 | -41.40 | 109.7K | Off |
| 8 May 2026 | 2.42 EUR | 4.0% | 3.75 EUR | 3.87 EUR | -1.41 | -43.48 | 33.6K | Off |
| 1 May 2026 | 2.32 EUR | -0.7% | 3.82 EUR | 3.89 EUR | -1.50 | -45.22 | 18.1K | Off |
| 24 Apr 2026 | 2.34 EUR | -6.6% | 3.91 EUR | 3.91 EUR | -1.51 | -44.87 | 66.8K | Off |
| 17 Apr 2026 | 2.50 EUR | -7.2% | 3.97 EUR | 3.92 EUR | -1.32 | -43.56 | 35.8K | Off |
| 10 Apr 2026 | 2.70 EUR | -0.1% | 4.04 EUR | 3.94 EUR | -0.72 | -38.20 | 14.8K | Off |
| 3 Apr 2026 | 2.70 EUR | -1.8% | 4.07 EUR | 3.95 EUR | -0.13 | -34.58 | 26.2K | Off |
| 27 Mar 2026 | 2.75 EUR | -37.5% | 4.09 EUR | 3.97 EUR | 0.53 | -31.37 | 152.3K | Off |
| 20 Mar 2026 | 4.40 EUR | -3.5% | 4.13 EUR | 3.97 EUR | 0.95 | 10.69 | 98.5K | On |
| 13 Mar 2026 | 4.56 EUR | -3.5% | 4.15 EUR | 3.95 EUR | 1.02 | 13.37 | 58.2K | On |